Bolt Biotherapeutics (BOLT) Misses Q3 EPS by 372c

Bolt Biotherapeutics (NASDAQ: BOLT) reported Q3 EPS of ($3.72). Revenue for the quarter came in at $2.17 million.

For earnings history and earnings-related data on Bolt Biotherapeutics (BOLT) click here.

You May Also Be Interested In

• loanDepot receives NYSE non-compliance notice over stock price
• Nuvectis Pharma (NVCT) files $200M mixed shelf
• Myriad Uranium completes acquisition of Rush Rare Metals